Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings

Shares (Q2 2026)
413
Value
$10.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NRIX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026413$10.0K<0.1%+164+65.9%AddedHolders
Q1 2026249$3.86K<0.1%+47+23.3%AddedHolders
Q4 2025202$3.83K<0.1%−28−12.2%ReducedHolders
Q3 2025230$2.13K<0.1%00.0%UnchangedHolders
Q2 2025230$2.62K<0.1%−12−5.0%ReducedHolders
Q1 2025242$2.88K<0.1%−1,182−83.0%ReducedHolders
Q4 20241,424$26.8K<0.1%+842+144.7%AddedHolders
Q3 2024582$13.1K<0.1%−650−52.8%ReducedHolders
Q2 20241,232$25.7K<0.1%+928+305.3%AddedHolders
Q1 2024304$4.47K<0.1%+230+310.8%AddedHolders
Q4 202374$764<0.1%−113−60.4%ReducedHolders
Q3 2023187$1.47K<0.1%−640−77.4%ReducedHolders
Q2 2023827$8.26K<0.1%+8+1.0%AddedHolders
Q1 2023819$7.27K<0.1%+716+695.1%AddedHolders
Q4 2022103$1.13K<0.1%−166−61.7%ReducedHolders
Q3 2022269$4.00K<0.1%+195+263.5%AddedHolders
Q2 202274$1.00K<0.1%00.0%UnchangedHolders
Q1 202274$1.00K<0.1%−52−41.3%ReducedHolders
Q4 2021126$4.00K<0.1%+74+142.3%AddedHolders
Q3 202152$2.00K<0.1%−109−67.7%ReducedHolders
Q2 2021161$4.00K<0.1%+153+1,912.5%AddedHolders
Q1 20218$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.